Zhu, Andrew X.; Finn, Richard S.; Galle, Peter R. et al.
Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of alpha-fetoproteinLANCET ONCOLOGY. Bd. 20. H. 4. 2019 S. E191-E191
Llovet, J.; Kudo, M.; Kang, Y-K. et al.
Ramucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysisANNALS OF ONCOLOGY. Bd. 30. 2019 S. 293-+
Kim, Yong Ook; Park, Kyoung-Sook; Schuessler, Christoph et al.
RAPIDLY PROGRESSIVE, POLYCLONAL ORTHOTOPIC HEPATOCELLULAR CARCINOMA (HCC) IN MDR2 (abcb4) KNOCKOUT MICE TREATED WITH DIETHYLNITROSAMINE AND PHENOBARBITALHEPATOLOGY. Bd. 70. 2019 S. 1208A-1209A
Goepfert, Katrin; Dinsart, Christiane; Rommelaere, Jean et al.
Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune SilencingFRONTIERS IN ONCOLOGY. Bd. 9. 2019
Schattenberg, Joern M.
Reading the stars for hepatic fibrosis or how to predict the severity of liver disease in patients with NASHLIVER INTERNATIONAL. Bd. 39. H. 5. 2019 S. 812-814
John, Sneha; Ostrowski, Szymon; Neumann, Helmut
REAL TIME DIAGNOSTIC ACCURACY OF BLUE LIGHT IMAGING WITH MAGNIFICATION (BLI) IN THE CHARACTERISATION OF SESSILE SERRATED POLYPS (SSPS) AND ADVANCED HISTOLOGY WITHIN COLORECTAL POLYPSGASTROINTESTINAL ENDOSCOPY. Bd. 89. H. 6. 2019 S. AB374-AB374
Schattenberg, Joern; Stoehr, Albrecht; Cornberg, Markus et al.
REAL-WORLD EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR (EBR/GZR) TREATMENT FOR HCV GENOTYPE 1 (GT1) INFECTION IN PATIENTS WITH DIABETES MELLITUS: RESULTS FROM THE GERMAN HEPATITIS C REGISTRY (DHC-R)HEPATOLOGY. Bd. 70. 2019 S. 990A-991A
Schattenberg, Joern M.; Loomba, Rohit
Refining Noninvasive Diagnostics In Nonalcoholic Fatty Liver Disease: Closing the Gap to Detect Advanced FibrosisHEPATOLOGY. Bd. 69. H. 3. 2019 S. 934-936
Holch, J. W.; Ricard, I.; Stintzing, S. et al.
Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)EUROPEAN JOURNAL OF CANCER. Bd. 106. 2019 S. 115-125
Rinella, Mary E.; Tacke, Frank; Sanyal, Arjun J. et al.
Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLDHEPATOLOGY. 2019